obiltoxaximab   Click here for help

GtoPdb Ligand ID: 13342

Synonyms: Anthim® | ETI-204 | Nyxthracis®
Approved drug
obiltoxaximab is an approved drug (FDA (2016), EMA (2020))
Compound class: Antibody
Comment: Obiltoxaximab is a chimeric IgG1 kappa monoclonal antibody that binds the protective antigen (PA) component of Bacillus anthracis toxin.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
No information available.
Summary of Clinical Use Click here for help
Obiltoxaximab (Anthim®) is approved to treat inhalational anthrax in combination with antibiotics [1].
External links Click here for help
For extended ADME data see the following:

Drugs.com
European Medicines Agency (EMA)